Pfizer PBC 125 Pill - purple oval, 16mm
Generic Name: palbociclib
Pill with imprint Pfizer PBC 125 is Purple, Oval and has been identified as Ibrance 125 mg. It is supplied by Pfizer Inc.
Ibrance is used in the treatment of Breast Cancer, Metastatic; Liposarcoma; Breast Cancer; Breast Cancer, Male and belongs to the drug class CDK 4/6 inhibitors. Ibrance 125 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Pfizer PBC 125
Ibrance
- Generic Name
- palbociclib
- Imprint
- Pfizer PBC 125
- Strength
- 125 mg
- Color
- Purple
- Size
- 16.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- CDK 4/6 inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pfizer Inc.
- National Drug Code (NDC)
- 00069-0688
Related images for "Pfizer PBC 125"
More about Ibrance (palbociclib)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (77)
- Drug images
- Latest FDA alerts (1)
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Generic availability
- FDA approval history
- Drug class: CDK 4/6 inhibitors
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.